These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32946982)

  • 1. Detection of chemotherapy-resistant patient-derived acute lymphoblastic leukemia clones in murine xenografts using cellular barcodes.
    Jacobs S; Ausema A; Zwart E; Weersing E; de Haan G; Bystrykh LV; Belderbos ME
    Exp Hematol; 2020 Nov; 91():46-54. PubMed ID: 32946982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal selection and asymmetric distribution of human leukemia in murine xenografts revealed by cellular barcoding.
    Belderbos ME; Koster T; Ausema B; Jacobs S; Sowdagar S; Zwart E; de Bont E; de Haan G; Bystrykh LV
    Blood; 2017 Jun; 129(24):3210-3220. PubMed ID: 28396495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.
    Nowak D; Liem NL; Mossner M; Klaumünzer M; Papa RA; Nowak V; Jann JC; Akagi T; Kawamata N; Okamoto R; Thoennissen NH; Kato M; Sanada M; Hofmann WK; Ogawa S; Marshall GM; Lock RB; Koeffler HP
    Exp Hematol; 2015 Jan; 43(1):32-43.e1-35. PubMed ID: 25450514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies.
    Liem NL; Papa RA; Milross CG; Schmid MA; Tajbakhsh M; Choi S; Ramirez CD; Rice AM; Haber M; Norris MD; MacKenzie KL; Lock RB
    Blood; 2004 May; 103(10):3905-14. PubMed ID: 14764536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative distribution of patient-derived leukemia clones in murine xenografts revealed by cellular barcodes.
    Jacobs S; Ausema A; Zwart E; Weersing E; Kingma MJ; El Menshawi YAS; de Haan G; Bystrykh LV; Belderbos ME
    Leukemia; 2020 Jun; 34(6):1669-1674. PubMed ID: 31852987
    [No Abstract]   [Full Text] [Related]  

  • 6. Donor-to-Donor Heterogeneity in the Clonal Dynamics of Transplanted Human Cord Blood Stem Cells in Murine Xenografts.
    Belderbos ME; Jacobs S; Koster TK; Ausema A; Weersing E; Zwart E; de Haan G; Bystrykh LV
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):16-25. PubMed ID: 31494231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia.
    Yadav BD; Samuels AL; Wells JE; Sutton R; Venn NC; Bendak K; Anderson D; Marshall GM; Cole CH; Beesley AH; Kees UR; Lock RB
    Oncotarget; 2016 Sep; 7(37):58728-42. PubMed ID: 27623214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia.
    Oshima K; Khiabanian H; da Silva-Almeida AC; Tzoneva G; Abate F; Ambesi-Impiombato A; Sanchez-Martin M; Carpenter Z; Penson A; Perez-Garcia A; Eckert C; Nicolas C; Balbin M; Sulis ML; Kato M; Koh K; Paganin M; Basso G; Gastier-Foster JM; Devidas M; Loh ML; Kirschner-Schwabe R; Palomero T; Rabadan R; Ferrando AA
    Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11306-11311. PubMed ID: 27655895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the clonal growth and differentiation dynamics of primitive barcoded human cord blood cells in NSG mice.
    Cheung AM; Nguyen LV; Carles A; Beer P; Miller PH; Knapp DJ; Dhillon K; Hirst M; Eaves CJ
    Blood; 2013 Oct; 122(18):3129-37. PubMed ID: 24030380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance.
    Chiu PP; Jiang H; Dick JE
    Blood; 2010 Dec; 116(24):5268-79. PubMed ID: 20810926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High level resistance to glucocorticoids, associated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance.
    Catts VS; Farnsworth ML; Haber M; Norris MD; Lutze-Mann LH; Lock RB
    Leukemia; 2001 Jun; 15(6):929-35. PubMed ID: 11417479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
    Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal analysis revealed functional heterogeneity in cancer stem-like cell phenotypes in uterine endometrioid adenocarcinoma.
    Tabuchi Y; Hirohashi Y; Hashimoto S; Mariya T; Asano T; Ikeo K; Kuroda T; Mizuuchi M; Murai A; Uno S; Kawai N; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Saito T; Torigoe T
    Exp Mol Pathol; 2019 Feb; 106():78-88. PubMed ID: 30503404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
    Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
    Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse.
    Lock RB; Liem N; Farnsworth ML; Milross CG; Xue C; Tajbakhsh M; Haber M; Norris MD; Marshall GM; Rice AM
    Blood; 2002 Jun; 99(11):4100-8. PubMed ID: 12010813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia.
    Samuels AL; Beesley AH; Yadav BD; Papa RA; Sutton R; Anderson D; Marshall GM; Cole CH; Kees UR; Lock RB
    Blood Cancer J; 2014 Aug; 4(8):e232. PubMed ID: 25083816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
    Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
    Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variegation of clonal architecture and propagating cells in leukaemia.
    Anderson K; Lutz C; van Delft FW; Bateman CM; Guo Y; Colman SM; Kempski H; Moorman AV; Titley I; Swansbury J; Kearney L; Enver T; Greaves M
    Nature; 2011 Jan; 469(7330):356-61. PubMed ID: 21160474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative utility of NRG and NRGS mice for the study of normal hematopoiesis, leukemogenesis, and therapeutic response.
    Barve A; Casson L; Krem M; Wunderlich M; Mulloy JC; Beverly LJ
    Exp Hematol; 2018 Nov; 67():18-31. PubMed ID: 30125602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia.
    Jin B; Wang C; Li J; Du X; Ding K; Pan J
    Clin Cancer Res; 2017 Feb; 23(3):789-803. PubMed ID: 27492973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.